Bacitraycin MAX Pain Relief
- Product NDC
- 52412-725
- Requested package NDC
- 52412-725-01
- 11-digit product format
- 524120725
- Labeler code
- 52412
- Product ID
- 52412-725_db747368-d45f-64e3-e053-2995a90a1fb8
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Bacitracin Zinc Pramoxine HCl
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Labeler
- Randob Labs Ltd.
- Application
- part333B
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2022-03-30
- Marketing end
- 0000-00-00
- Substance
- BACITRACIN ZINC; PRAMOXINE HYDROCHLORIDE
- Active strength
- 500 [USP'U]/g; mg/g
- Pharmacologic classes
- Decreased Cell Wall Synthesis & Repair [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Dashboard NDC Coverage#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 52412-725-01 | 52412072501 | 1 TUBE in 1 CARTON (52412-725-01) > 28 g in 1 TUBE | 1 tube | 2022-03-30 | 0000-00-00 | No | No | Current |